VIVO
Weill Cornell Medical College
Index
Log in
Search form
Home
People
Organizations
Research
Events
Capability Map
CoVPN 3001: Phase 3, SARS-CoV-2 Vaccine (Moderna TX, Inc.)
Grant
Overview
date/time interval
July 1, 2020 - November 30, 2023
awarded by
National Institute of Allergy & Infectious Diseases
administered by
Medicine-Infectious Diseases
sponsor award ID
1 UM1 AI068619-01
Affiliation
contributor
Marks, Kristen
Principal Investigator (Subaward)
2020 - 2023